IP Library Granted Patent US 8,039,221
Granted Patent B2
US 8,039,221 · App. 12/486,972 · Granted Oct 18, 2011

Methods for identifying and using MarR family polypeptide binding compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,039,221
App. No.
12/486,972
Granted
Oct 18, 2011
Kind
B2
Abstract

Methods for identifying MarR family inhibiting compounds are described. The methods include the use of computer aided rational based drug design programs and three dimensional structures of MarR family polypeptides.

Claims (15)

1. A method for inhibiting expression of MarA, comprising contacting MarR with a MarR modulating compound, wherein said MarR modulating compound is of the formula:

wherein, X is an interacting moiety selected from the group consisting of hydroxyl, thiol, sulfonyl, sulfonyl, amino, carbonyl, alkyl, and acyl moieties;

Y is a selected from the group consisting of substituted or unsubstituted cyclic or bicyclic moiety, optionally substituted with a hydrophilic substituent; and

wherein X and the carboxylate group of said formula are separated by a distance of about 1.5 Angstroms.

2. The method of claim 1 wherein the MarR modulating compound is a MarR activator.

3. The method of claim 1 wherein said interacting moiety X interacts with the amino acid Asn corresponding to position 72 of SEQ ID NO:1.

4. The method of claim 1 wherein said interacting moiety X interacts with the amino acid Asn corresponding to position 70 of SEQ ID NO:1.

5. The method of claim 1 , wherein X is a hydroxy, thiol or amino.

6. The method of claim 1 , wherein Y is aryl.

7. The method of claim 1 , wherein Y is capable of interacting hydrophobically with the corresponding amino acid positions Asp 57 or Lys 74 of SEQ ID NO:1.

8. The method of claim 1 , wherein the MarR modulating compound is a MarR inhibitor.

9. The method of claim 1 , wherein X is hydroxyl.

10. The method of claim 1 , wherein Y is monocyclic.

11. The method of claim 1 , wherein Y is bicyclic.

12. The method of 1 wherein the MarR modulating compound is selected from the group consisting of:

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2014
From: HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD., AS COLLATERAL AGENT
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 034113/0910 →
SECURITY INTEREST Recorded Mar 14, 2014
From: PARATEK PHARMACEUTICALS, INC.
To: HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD., AS COLLATERAL AGENT
Reel/Frame 032448/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2010
From: ALEKSHUN, MICHAEL N.; LEVY, STUART B.; PODLOGAR, BRENT L.; FRECHETTE, ROGER
To: PARATEK PHARMACEUTICALS, INC.
Reel/Frame 023911/0191 →